<DOC>
	<DOCNO>NCT00120250</DOCNO>
	<brief_summary>The purpose study obtain data investigate safety efficacy eszopiclone treatment post-traumatic stress disorder ( PTSD ) -related sleep disturbance impact improve sleep eszopiclone treatment neuroendocrine correlate PTSD . The investigator hypothesize eszopiclone significantly effective placebo well tolerate PTSD-related sleep disturbance , improvement sleep associate improvement overall PTSD symptom , patient PTSD-related sleep disturbance abnormal level stress hormone .</brief_summary>
	<brief_title>Eszopiclone Sleep Disturbance Nightmares Post-Traumatic Stress Disorder</brief_title>
	<detailed_description>Post-traumatic stress disorder ( PTSD ) characterize three symptom grouping : re-experiencing symptom include flashback , nightmare , intrusive memory ; physiological hyperarousal ; avoidance symptom . Of three major category symptoms PTSD list Diagnostic Statistical Manual Mental Disorders , sleep-related problem list two : difficulty fall asleep consider aspect hyperarousal symptom , nightmare type re-experiencing symptom . Both find commonly PTSD . Little known relationship neuroendocrine dysregulation PTSD sleep disturbance . It possible successful treatment sleep disturbance PTSD may alter abnormal stress hormone pattern . The novel cyclopyrrolone hypnotic eszopiclone thus present intriguing opportunity examine treatment sleep disturbance nightmare PTSD . This study determine safety , efficacy impact neuroendocrine parameter eszopiclone compare placebo sleep disturbance overall PTSD symptom individual PTSD report sleep disturbance .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Dyssomnias</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Eszopiclone</mesh_term>
	<criteria>Male female outpatient 1864 year age primary diagnosis PTSD define DSMIV criterion associate sleep disturbance Pregnant woman , lactate woman , woman childbearing potential use medically accept form contraception . Concurrent use psychotropic medication , antidepressant stable dose least 4 week prior randomization Serious medical illness instability Seizure disorder exception history febrile seizure occur childhood Concurrent psychotherapy initiate within one month randomization ongoing psychotherapy duration direct specifically toward treatment PTSD and/or sleep disturbance Diagnosis schizophrenia , mental retardation , OCD , organic medical disorder bipolar disorder , eat disorder past 6 month , alcohol substance abuse past 3 month , dependence within past 6 month . Patients significant suicidal ideation enact suicidal behavior within 6 month prior intake</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>PTSD</keyword>
	<keyword>Sleep disturbance</keyword>
	<keyword>Eszopiclone</keyword>
	<keyword>Double-blind</keyword>
	<keyword>Crossover</keyword>
</DOC>